Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

2.40
Delayed Data
As of 11:57am ET
 +0.005 / +0.21%
Today’s Change
1.88
Today|||52-Week Range
4.38
+0.63%
Year-to-Date
No recent news for Rigel Pharmaceuticals Inc.

Today’s Trading

Previous close2.39
Today’s open2.40
Day’s range2.39 - 2.44
Volume241,736
Average volume (3 months)1,122,413
Market cap$284.2M
Dividend yield--
Data as of 11:57am ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)+44.23%
Earnings growth (this year)-28.12%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+250.24%
P/E ratioNM
Price/Sales9.27
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...-0.08-1.88%
ADAPAdaptimmune Therapeu...+0.16+3.89%
EDGEEdge Therapeutics In...+0.19+1.87%
ONVOOrganovo Holdings In...+0.01+0.34%
Data as of 12:09pm ET, 02/21/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$28.9M
Annual profit (last year)-$51.5M
Net profit margin-178.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs